<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[NHS Liverpool Clinical Commissioning Group 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=39657></link><description><![CDATA[NHS Liverpool Clinical Commissioning Group 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 20 May 2026 22:36:02 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/01/12_1026003021_20220113103622_2332828337.gif]]></url></image><language>ko-KR</language><item><title><![CDATA[Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies]]></title><link>https://www.newswire.co.kr/newsRead.php?no=938061</link><description><![CDATA[LIVERPOOL, England--(Business Wire/Korea Newswire)--Today, Liverpool Clinical Commissioning Group (CCG) and Community Pharmacy Liverpool kicked off a new clinical service that will allow more than 100 pharmacies to offer a 10-minute, point-of-care test to differentiate bacterial from viral respiratory infection.  The test, named FebriDx®, will be used for patients with an acute cough at pharmacie...]]></description><pubDate>Thu, 13 Jan 2022 11:10:00 +0900</pubDate></item><item><title><![CDATA[리버풀 CCG와 리버풀 지역 약국 협회, 100곳 이상의 지역 약국에서 FebriDx® 서비스 제공]]></title><link>https://www.newswire.co.kr/newsRead.php?no=938062</link><description><![CDATA[리버풀, 영국--(Business Wire/뉴스와이어)--리버풀 의료 위탁 그룹(Clinical Commissioning Group, 약칭 CCG)과 리버풀 지역 약국 협회(Community Pharmacy Liverpool)가 세균성 또는 바이러스성 호흡기 감염을 10분 만에 판별하는 현장 검사(point-of-care)인 FebriDx® 서비스를 시작했다.  FebriDx®는 경미한 질병에 대한 ‘약국 우선 서비스(Pharmacy First)’ 정책에 따라 리버풀 전역의 100개 이상의 약국에서 제공...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2022/01/1026003021_20220113104442_8303561269.jpg]]></url></image><pubDate>Thu, 13 Jan 2022 11:10:00 +0900</pubDate></item></channel></rss>